A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-04-14

AUTHORS

Yan Yiannakou, Hubert Piessevaux, Michel Bouchoucha, Ingolf Schiefke, Rafal Filip, Libor Gabalec, Ion Dina, David Stephenson, René Kerstens, Kevin Etherson, Amy Levine

ABSTRACT

OBJECTIVES: Prucalopride is effective at alleviating symptoms of chronic constipation in women. The aim of this study was to assess the efficacy of 12 weeks of prucalopride treatment compared with placebo in men with chronic constipation. METHODS: This was a multicenter, stratified, randomized, parallel-group, double-blind, placebo-controlled, phase 3 study (ClinicalTrials.gov identifier: NCT01147926). The primary end point was the proportion of patients with a mean of three or more spontaneous complete bowel movements (SCBMs) per week across the treatment period. Efficacy end points were assessed using daily electronic diaries, global assessment of the severity of constipation and efficacy of treatment, and Patient Assessment of Constipation-Symptoms (PAC-SYM) and Patient Assessment of Constipation-Quality of Life (PAC-QOL) questionnaires. RESULTS: In total, 374 patients were enrolled in the study. Significantly more patients achieved a mean of three or more SCBMs per week in the prucalopride group (37.9%) than in the placebo group (17.7%, P<0.0001). The proportion of patients rating their constipation treatment as "quite a bit" to "extremely" effective at the final on-treatment visit was 46.7 and 30.4% in the prucalopride and placebo groups, respectively. The difference between treatment groups was statistically significant (P<0.0001). The proportion of patients with an improvement of at least 1 point in PAC-QOL satisfaction subscale score was 52.7 and 38.8% in the prucalopride and placebo groups, respectively (P=0.0035). Prucalopride had a good safety profile and was well tolerated. CONCLUSIONS: Prucalopride is effective, has a good safety profile, and is well tolerated for the treatment of men with chronic constipation. More... »

PAGES

741

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/ajg.2015.115

DOI

http://dx.doi.org/10.1038/ajg.2015.115

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1004237417

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25869393


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Abdominal Pain", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzofurans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chronic Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Defecation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diarrhea", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Headache", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medical Records", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nausea", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality of Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serotonin 5-HT4 Receptor Agonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surveys and Questionnaires", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology, County Durham and Darlington NHS Foundation Trust, Durham, UK", 
          "id": "http://www.grid.ac/institutes/grid.412907.9", 
          "name": [
            "Department of Gastroenterology, County Durham and Darlington NHS Foundation Trust, Durham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yiannakou", 
        "givenName": "Yan", 
        "id": "sg:person.0634340502.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634340502.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cliniques Universitaires Saint-Luc, Universit\u00e9 Catholique de Louvain, Brussels, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.48769.34", 
          "name": [
            "Cliniques Universitaires Saint-Luc, Universit\u00e9 Catholique de Louvain, Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Piessevaux", 
        "givenName": "Hubert", 
        "id": "sg:person.0575631433.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575631433.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e9 Paris V-Ren\u00e9-Descartes, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.508487.6", 
          "name": [
            "Universit\u00e9 Paris V-Ren\u00e9-Descartes, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bouchoucha", 
        "givenName": "Michel", 
        "id": "sg:person.01013417021.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013417021.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00ecr Gastroenterologie und Hepatologie, Klinikum St Georg, Leipzig, Germany", 
          "id": "http://www.grid.ac/institutes/grid.470221.2", 
          "name": [
            "Klinik f\u00ecr Gastroenterologie und Hepatologie, Klinikum St Georg, Leipzig, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schiefke", 
        "givenName": "Ingolf", 
        "id": "sg:person.01104777015.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104777015.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Rural Health, Lublin, Poland", 
          "id": "http://www.grid.ac/institutes/grid.460395.d", 
          "name": [
            "Institute of Rural Health, Lublin, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Filip", 
        "givenName": "Rafal", 
        "id": "sg:person.0612654064.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612654064.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Orlicko\u00fasteck\u00e1 nemocnice, \u00dast\u00ed nad Orlic\u00ed, Czech Republic", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Orlicko\u00fasteck\u00e1 nemocnice, \u00dast\u00ed nad Orlic\u00ed, Czech Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gabalec", 
        "givenName": "Libor", 
        "id": "sg:person.0600774135.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600774135.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Medicine and Pharmacy Carol Davila, Bucharest, Romania", 
          "id": "http://www.grid.ac/institutes/grid.8194.4", 
          "name": [
            "University of Medicine and Pharmacy Carol Davila, Bucharest, Romania"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dina", 
        "givenName": "Ion", 
        "id": "sg:person.0630714233.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630714233.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Shire, Basingstoke, UK", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Shire, Basingstoke, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stephenson", 
        "givenName": "David", 
        "id": "sg:person.01255001435.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255001435.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Shire-Movetis NV, Turnhout, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.476699.3", 
          "name": [
            "Shire-Movetis NV, Turnhout, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kerstens", 
        "givenName": "Ren\u00e9", 
        "id": "sg:person.01100761327.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100761327.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology, County Durham and Darlington NHS Foundation Trust, Durham, UK", 
          "id": "http://www.grid.ac/institutes/grid.412907.9", 
          "name": [
            "Department of Gastroenterology, County Durham and Darlington NHS Foundation Trust, Durham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Etherson", 
        "givenName": "Kevin", 
        "id": "sg:person.012027475043.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012027475043.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Shire, Wayne, Pennsylvania, USA", 
          "id": "http://www.grid.ac/institutes/grid.475962.b", 
          "name": [
            "Shire, Wayne, Pennsylvania, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Levine", 
        "givenName": "Amy", 
        "id": "sg:person.01372263205.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372263205.24"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1111/j.1572-0241.2002.05843.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015905931", 
          "https://doi.org/10.1111/j.1572-0241.2002.05843.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2011.164", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033854120", 
          "https://doi.org/10.1038/ajg.2011.164"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-04-14", 
    "datePublishedReg": "2015-04-14", 
    "description": "OBJECTIVES: Prucalopride is effective at alleviating symptoms of chronic constipation in women. The aim of this study was to assess the efficacy of 12 weeks of prucalopride treatment compared with placebo in men with chronic constipation.\nMETHODS: This was a multicenter, stratified, randomized, parallel-group, double-blind, placebo-controlled, phase 3 study (ClinicalTrials.gov identifier: NCT01147926). The primary end point was the proportion of patients with a mean of three or more spontaneous complete bowel movements (SCBMs) per week across the treatment period. Efficacy end points were assessed using daily electronic diaries, global assessment of the severity of constipation and efficacy of treatment, and Patient Assessment of Constipation-Symptoms (PAC-SYM) and Patient Assessment of Constipation-Quality of Life (PAC-QOL) questionnaires.\nRESULTS: In total, 374 patients were enrolled in the study. Significantly more patients achieved a mean of three or more SCBMs per week in the prucalopride group (37.9%) than in the placebo group (17.7%, P<0.0001). The proportion of patients rating their constipation treatment as \"quite a bit\" to \"extremely\" effective at the final on-treatment visit was 46.7 and 30.4% in the prucalopride and placebo groups, respectively. The difference between treatment groups was statistically significant (P<0.0001). The proportion of patients with an improvement of at least 1 point in PAC-QOL satisfaction subscale score was 52.7 and 38.8% in the prucalopride and placebo groups, respectively (P=0.0035). Prucalopride had a good safety profile and was well tolerated.\nCONCLUSIONS: Prucalopride is effective, has a good safety profile, and is well tolerated for the treatment of men with chronic constipation.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/ajg.2015.115", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1412991", 
        "issn": [
          "0002-9270", 
          "1572-0241"
        ], 
        "name": "The American Journal of Gastroenterology", 
        "publisher": "Wolters Kluwer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "110"
      }
    ], 
    "keywords": [
      "spontaneous complete bowel movements", 
      "proportion of patients", 
      "chronic constipation", 
      "good safety profile", 
      "placebo group", 
      "patient assessment", 
      "safety profile", 
      "end point", 
      "tolerability of prucalopride", 
      "primary end point", 
      "efficacy end point", 
      "phase 3 study", 
      "phase 3 trial", 
      "severity of constipation", 
      "complete bowel movements", 
      "daily electronic diary", 
      "treatment of men", 
      "satisfaction subscale scores", 
      "efficacy of treatment", 
      "prucalopride treatment", 
      "Constipation Quality", 
      "prucalopride group", 
      "bowel movements", 
      "constipation treatment", 
      "more patients", 
      "treatment visits", 
      "Life Questionnaire", 
      "treatment period", 
      "prucalopride", 
      "constipation", 
      "treatment groups", 
      "patients", 
      "global assessment", 
      "electronic diary", 
      "subscale scores", 
      "weeks", 
      "placebo", 
      "efficacy", 
      "treatment", 
      "men", 
      "group", 
      "proportion", 
      "multicenter", 
      "tolerability", 
      "assessment", 
      "symptoms", 
      "visits", 
      "trials", 
      "severity", 
      "women", 
      "study", 
      "total", 
      "scores", 
      "questionnaire", 
      "safety", 
      "diary", 
      "aim", 
      "profile", 
      "period", 
      "differences", 
      "improvement", 
      "means", 
      "point", 
      "movement", 
      "bits"
    ], 
    "name": "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation", 
    "pagination": "741", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1004237417"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/ajg.2015.115"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25869393"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/ajg.2015.115", 
      "https://app.dimensions.ai/details/publication/pub.1004237417"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_667.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/ajg.2015.115"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/ajg.2015.115'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/ajg.2015.115'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/ajg.2015.115'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/ajg.2015.115'


 

This table displays all metadata directly associated to this object as RDF triples.

302 TRIPLES      21 PREDICATES      110 URIs      100 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/ajg.2015.115 schema:about N0bb01411d8274a64b3045d0039b354f4
2 N2031da27140941658da3ec0ca83972c1
3 N22ceed005e5b4ac4ac935073edf30248
4 N2828911205f94cc2b320e9d1f45e7a6f
5 N3d3df2c50d15422db5a7abed07dd65b4
6 N44e3a1a48c7044e6a3f069b14edef519
7 N4c2cfc1c26684089a8fbfed2705166de
8 N697a5f020e9248b8bf2e9f12c153e335
9 N952c975367fb4bd392e67f4e1ff2517d
10 Nb465d0092f3b4c8fad071f98187cb95d
11 Nb929e6991cab4c99b1e086962d9a62eb
12 Nb93638d2c0ab416291588bf0cfb7bd1e
13 Nbf5db5ba55e54d1b9a5c65cd30c9d6f7
14 Nd4d205fed4ad4d5ea0db046ce75b3a2b
15 Nd615568f0b4442bd97a782e4cc31b6e2
16 Nd83c3469d8d2455099c5210a1b6d81a1
17 Ndb1f3e7ada50454782b2404c8be88295
18 Nea1bc86f80d147248735f014ecb50aa5
19 anzsrc-for:11
20 anzsrc-for:1103
21 schema:author N0885fa067f1545f5a5d7721f175a12db
22 schema:citation sg:pub.10.1038/ajg.2011.164
23 sg:pub.10.1111/j.1572-0241.2002.05843.x
24 schema:datePublished 2015-04-14
25 schema:datePublishedReg 2015-04-14
26 schema:description OBJECTIVES: Prucalopride is effective at alleviating symptoms of chronic constipation in women. The aim of this study was to assess the efficacy of 12 weeks of prucalopride treatment compared with placebo in men with chronic constipation. METHODS: This was a multicenter, stratified, randomized, parallel-group, double-blind, placebo-controlled, phase 3 study (ClinicalTrials.gov identifier: NCT01147926). The primary end point was the proportion of patients with a mean of three or more spontaneous complete bowel movements (SCBMs) per week across the treatment period. Efficacy end points were assessed using daily electronic diaries, global assessment of the severity of constipation and efficacy of treatment, and Patient Assessment of Constipation-Symptoms (PAC-SYM) and Patient Assessment of Constipation-Quality of Life (PAC-QOL) questionnaires. RESULTS: In total, 374 patients were enrolled in the study. Significantly more patients achieved a mean of three or more SCBMs per week in the prucalopride group (37.9%) than in the placebo group (17.7%, P<0.0001). The proportion of patients rating their constipation treatment as "quite a bit" to "extremely" effective at the final on-treatment visit was 46.7 and 30.4% in the prucalopride and placebo groups, respectively. The difference between treatment groups was statistically significant (P<0.0001). The proportion of patients with an improvement of at least 1 point in PAC-QOL satisfaction subscale score was 52.7 and 38.8% in the prucalopride and placebo groups, respectively (P=0.0035). Prucalopride had a good safety profile and was well tolerated. CONCLUSIONS: Prucalopride is effective, has a good safety profile, and is well tolerated for the treatment of men with chronic constipation.
27 schema:genre article
28 schema:isAccessibleForFree true
29 schema:isPartOf N71fdacca7ab544cd86ce0c9950595d09
30 N803c8931fb38425fb7736d08f37b08c3
31 sg:journal.1412991
32 schema:keywords Constipation Quality
33 Life Questionnaire
34 aim
35 assessment
36 bits
37 bowel movements
38 chronic constipation
39 complete bowel movements
40 constipation
41 constipation treatment
42 daily electronic diary
43 diary
44 differences
45 efficacy
46 efficacy end point
47 efficacy of treatment
48 electronic diary
49 end point
50 global assessment
51 good safety profile
52 group
53 improvement
54 means
55 men
56 more patients
57 movement
58 multicenter
59 patient assessment
60 patients
61 period
62 phase 3 study
63 phase 3 trial
64 placebo
65 placebo group
66 point
67 primary end point
68 profile
69 proportion
70 proportion of patients
71 prucalopride
72 prucalopride group
73 prucalopride treatment
74 questionnaire
75 safety
76 safety profile
77 satisfaction subscale scores
78 scores
79 severity
80 severity of constipation
81 spontaneous complete bowel movements
82 study
83 subscale scores
84 symptoms
85 tolerability
86 tolerability of prucalopride
87 total
88 treatment
89 treatment groups
90 treatment of men
91 treatment period
92 treatment visits
93 trials
94 visits
95 weeks
96 women
97 schema:name A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation
98 schema:pagination 741
99 schema:productId N78017202f3914c00b6bc260a484604f3
100 Na625a2a37aef4cbeb761d79ee8690854
101 Ne2a814e04c9d4b2fb5b19034e545d3ad
102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004237417
103 https://doi.org/10.1038/ajg.2015.115
104 schema:sdDatePublished 2022-09-02T15:58
105 schema:sdLicense https://scigraph.springernature.com/explorer/license/
106 schema:sdPublisher Ne956ffe7c82c42b3a0e2d18d646ad197
107 schema:url https://doi.org/10.1038/ajg.2015.115
108 sgo:license sg:explorer/license/
109 sgo:sdDataset articles
110 rdf:type schema:ScholarlyArticle
111 N0885fa067f1545f5a5d7721f175a12db rdf:first sg:person.0634340502.29
112 rdf:rest Ndab6d928036b414cb2592dfdb672bc1e
113 N0bb01411d8274a64b3045d0039b354f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Medical Records
115 rdf:type schema:DefinedTerm
116 N1fe90b1f1b5c4499a02a13b1fb441e68 rdf:first sg:person.01372263205.24
117 rdf:rest rdf:nil
118 N2031da27140941658da3ec0ca83972c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Nausea
120 rdf:type schema:DefinedTerm
121 N22ceed005e5b4ac4ac935073edf30248 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Headache
123 rdf:type schema:DefinedTerm
124 N2828911205f94cc2b320e9d1f45e7a6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Severity of Illness Index
126 rdf:type schema:DefinedTerm
127 N3d3df2c50d15422db5a7abed07dd65b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Double-Blind Method
129 rdf:type schema:DefinedTerm
130 N44e3a1a48c7044e6a3f069b14edef519 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Chronic Disease
132 rdf:type schema:DefinedTerm
133 N4c2cfc1c26684089a8fbfed2705166de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Quality of Life
135 rdf:type schema:DefinedTerm
136 N5feee8d9683c449283cf4c3027e7480e rdf:first sg:person.01255001435.88
137 rdf:rest Na4ec10d24e6f44018380ef23b5b9801d
138 N697a5f020e9248b8bf2e9f12c153e335 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Surveys and Questionnaires
140 rdf:type schema:DefinedTerm
141 N71fdacca7ab544cd86ce0c9950595d09 schema:volumeNumber 110
142 rdf:type schema:PublicationVolume
143 N78017202f3914c00b6bc260a484604f3 schema:name pubmed_id
144 schema:value 25869393
145 rdf:type schema:PropertyValue
146 N803c8931fb38425fb7736d08f37b08c3 schema:issueNumber 5
147 rdf:type schema:PublicationIssue
148 N88ec9e7e9ec1424fa83b84c8c1e8b30d rdf:first sg:person.0612654064.29
149 rdf:rest Na87e7ab611b84c2e87b6844d0b8cae63
150 N952c975367fb4bd392e67f4e1ff2517d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Middle Aged
152 rdf:type schema:DefinedTerm
153 Na10353b393774300a8c33bd73251338c rdf:first sg:person.012027475043.27
154 rdf:rest N1fe90b1f1b5c4499a02a13b1fb441e68
155 Na4ec10d24e6f44018380ef23b5b9801d rdf:first sg:person.01100761327.66
156 rdf:rest Na10353b393774300a8c33bd73251338c
157 Na625a2a37aef4cbeb761d79ee8690854 schema:name doi
158 schema:value 10.1038/ajg.2015.115
159 rdf:type schema:PropertyValue
160 Na87e7ab611b84c2e87b6844d0b8cae63 rdf:first sg:person.0600774135.81
161 rdf:rest Nc5800ca3cf974bc8b089c4c43546d585
162 Nb465d0092f3b4c8fad071f98187cb95d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Benzofurans
164 rdf:type schema:DefinedTerm
165 Nb929e6991cab4c99b1e086962d9a62eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Diarrhea
167 rdf:type schema:DefinedTerm
168 Nb93638d2c0ab416291588bf0cfb7bd1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Defecation
170 rdf:type schema:DefinedTerm
171 Nbf5db5ba55e54d1b9a5c65cd30c9d6f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Aged
173 rdf:type schema:DefinedTerm
174 Nc3f96ade63364f38aa2a29ce40ec0413 rdf:first sg:person.01104777015.13
175 rdf:rest N88ec9e7e9ec1424fa83b84c8c1e8b30d
176 Nc5800ca3cf974bc8b089c4c43546d585 rdf:first sg:person.0630714233.24
177 rdf:rest N5feee8d9683c449283cf4c3027e7480e
178 Nd4d205fed4ad4d5ea0db046ce75b3a2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Humans
180 rdf:type schema:DefinedTerm
181 Nd615568f0b4442bd97a782e4cc31b6e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Adult
183 rdf:type schema:DefinedTerm
184 Nd83c3469d8d2455099c5210a1b6d81a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Serotonin 5-HT4 Receptor Agonists
186 rdf:type schema:DefinedTerm
187 Ndab6d928036b414cb2592dfdb672bc1e rdf:first sg:person.0575631433.45
188 rdf:rest Nf2029d3c706b4036ac2a3c62fd95d234
189 Ndb1f3e7ada50454782b2404c8be88295 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Abdominal Pain
191 rdf:type schema:DefinedTerm
192 Ne2a814e04c9d4b2fb5b19034e545d3ad schema:name dimensions_id
193 schema:value pub.1004237417
194 rdf:type schema:PropertyValue
195 Ne956ffe7c82c42b3a0e2d18d646ad197 schema:name Springer Nature - SN SciGraph project
196 rdf:type schema:Organization
197 Nea1bc86f80d147248735f014ecb50aa5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Male
199 rdf:type schema:DefinedTerm
200 Nf2029d3c706b4036ac2a3c62fd95d234 rdf:first sg:person.01013417021.84
201 rdf:rest Nc3f96ade63364f38aa2a29ce40ec0413
202 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
203 schema:name Medical and Health Sciences
204 rdf:type schema:DefinedTerm
205 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
206 schema:name Clinical Sciences
207 rdf:type schema:DefinedTerm
208 sg:journal.1412991 schema:issn 0002-9270
209 1572-0241
210 schema:name The American Journal of Gastroenterology
211 schema:publisher Wolters Kluwer
212 rdf:type schema:Periodical
213 sg:person.01013417021.84 schema:affiliation grid-institutes:grid.508487.6
214 schema:familyName Bouchoucha
215 schema:givenName Michel
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013417021.84
217 rdf:type schema:Person
218 sg:person.01100761327.66 schema:affiliation grid-institutes:grid.476699.3
219 schema:familyName Kerstens
220 schema:givenName René
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100761327.66
222 rdf:type schema:Person
223 sg:person.01104777015.13 schema:affiliation grid-institutes:grid.470221.2
224 schema:familyName Schiefke
225 schema:givenName Ingolf
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104777015.13
227 rdf:type schema:Person
228 sg:person.012027475043.27 schema:affiliation grid-institutes:grid.412907.9
229 schema:familyName Etherson
230 schema:givenName Kevin
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012027475043.27
232 rdf:type schema:Person
233 sg:person.01255001435.88 schema:affiliation grid-institutes:None
234 schema:familyName Stephenson
235 schema:givenName David
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255001435.88
237 rdf:type schema:Person
238 sg:person.01372263205.24 schema:affiliation grid-institutes:grid.475962.b
239 schema:familyName Levine
240 schema:givenName Amy
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372263205.24
242 rdf:type schema:Person
243 sg:person.0575631433.45 schema:affiliation grid-institutes:grid.48769.34
244 schema:familyName Piessevaux
245 schema:givenName Hubert
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575631433.45
247 rdf:type schema:Person
248 sg:person.0600774135.81 schema:affiliation grid-institutes:None
249 schema:familyName Gabalec
250 schema:givenName Libor
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600774135.81
252 rdf:type schema:Person
253 sg:person.0612654064.29 schema:affiliation grid-institutes:grid.460395.d
254 schema:familyName Filip
255 schema:givenName Rafal
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612654064.29
257 rdf:type schema:Person
258 sg:person.0630714233.24 schema:affiliation grid-institutes:grid.8194.4
259 schema:familyName Dina
260 schema:givenName Ion
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630714233.24
262 rdf:type schema:Person
263 sg:person.0634340502.29 schema:affiliation grid-institutes:grid.412907.9
264 schema:familyName Yiannakou
265 schema:givenName Yan
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634340502.29
267 rdf:type schema:Person
268 sg:pub.10.1038/ajg.2011.164 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033854120
269 https://doi.org/10.1038/ajg.2011.164
270 rdf:type schema:CreativeWork
271 sg:pub.10.1111/j.1572-0241.2002.05843.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1015905931
272 https://doi.org/10.1111/j.1572-0241.2002.05843.x
273 rdf:type schema:CreativeWork
274 grid-institutes:None schema:alternateName Orlickoústecká nemocnice, Ústí nad Orlicí, Czech Republic
275 Shire, Basingstoke, UK
276 schema:name Orlickoústecká nemocnice, Ústí nad Orlicí, Czech Republic
277 Shire, Basingstoke, UK
278 rdf:type schema:Organization
279 grid-institutes:grid.412907.9 schema:alternateName Department of Gastroenterology, County Durham and Darlington NHS Foundation Trust, Durham, UK
280 schema:name Department of Gastroenterology, County Durham and Darlington NHS Foundation Trust, Durham, UK
281 rdf:type schema:Organization
282 grid-institutes:grid.460395.d schema:alternateName Institute of Rural Health, Lublin, Poland
283 schema:name Institute of Rural Health, Lublin, Poland
284 rdf:type schema:Organization
285 grid-institutes:grid.470221.2 schema:alternateName Klinik fìr Gastroenterologie und Hepatologie, Klinikum St Georg, Leipzig, Germany
286 schema:name Klinik fìr Gastroenterologie und Hepatologie, Klinikum St Georg, Leipzig, Germany
287 rdf:type schema:Organization
288 grid-institutes:grid.475962.b schema:alternateName Shire, Wayne, Pennsylvania, USA
289 schema:name Shire, Wayne, Pennsylvania, USA
290 rdf:type schema:Organization
291 grid-institutes:grid.476699.3 schema:alternateName Shire-Movetis NV, Turnhout, Belgium
292 schema:name Shire-Movetis NV, Turnhout, Belgium
293 rdf:type schema:Organization
294 grid-institutes:grid.48769.34 schema:alternateName Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
295 schema:name Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
296 rdf:type schema:Organization
297 grid-institutes:grid.508487.6 schema:alternateName Université Paris V-René-Descartes, Paris, France
298 schema:name Université Paris V-René-Descartes, Paris, France
299 rdf:type schema:Organization
300 grid-institutes:grid.8194.4 schema:alternateName University of Medicine and Pharmacy Carol Davila, Bucharest, Romania
301 schema:name University of Medicine and Pharmacy Carol Davila, Bucharest, Romania
302 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...